Erythrocin Lactobionate (Hospira, Inc.)
Welcome to the PulseAid listing for the Erythrocin Lactobionate drug offered from Hospira, Inc.. This Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hospira, Inc. |
| NON-PROPRIETARY NAME: | ERYTHROMYCIN LACTOBIONATE |
| SUBSTANCE NAME: | ERYTHROMYCIN LACTOBIONATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2006-03-16 |
| END MARKETING DATE: | 0000-00-00 |
Erythrocin Lactobionate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Erythrocin Lactobionate from Hospira, Inc. |
| LABELER NAME: | Hospira, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500(mg/100mL) |
| START MARKETING DATE: | 2006-03-16 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0409-6476_183ac37a-76a4-4174-aa1f-d59f886d0f20 |
| PRODUCT NDC: | 0409-6476 |
| APPLICATION NUMBER: | ANDA062638 |
Other ERYTHROMYCIN LACTOBIONATE Pharmaceutical Manufacturers / Labelers:
